ACTR-70. A MULTISITE CLINICAL TRIAL OF SPECTROSCOPIC MRI-GUIDED RADIATION DOSE ESCALATION IN GLIOBLASTOMA PATIENTS
Ontology highlight
ABSTRACT: Abstract The standard of care for glioblastoma is neurosurgical resection followed by radiation therapy (RT) and temozolomide (TMZ) chemotherapy. Although RT is effective for glioblastoma, attempts to improve survival using RT dose escalation above 60 Gy have been largely unsuccessful. This may be because prior attempts have been targeted to resection cavity or enhancing tumor, which may not accurately predict areas at highest recurrence risk. To overcome the limitations of standard T1 and T2-weighted MRI in predicting tumor recurrence, we have shown that supplementation with 3D high-resolution spectroscopic MRI (sMRI) identifies actively proliferating tumor beyond areas of T1-enhancement by measuring endogenous metabolites and their ratios. Previously, we demonstrated that the choline to
SUBMITTER: Mellon E
PROVIDER: S-EPMC6846992 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA